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Abstract 22 
Life-threatening systemic infections often occur due to the translocation of pathogens across 23 
the gut barrier and into the bloodstream. While the microbial and host mechanisms 24 
permitting bacterial gut translocation are well characterized, these are still unclear for fungal 25 
pathogens such as Candida albicans, a leading cause of nosocomial fungal bloodstream 26 
infections. In this study, we dissected the cellular mechanisms of translocation of C. albicans 27 
across intestinal epithelia in vitro and identified fungal genes associated with this process. 28 
We show that fungal translocation is a dynamic process initiated by invasion, and followed 29 
by cellular damage and loss of epithelial integrity. A screen of > 2000 C. albicans deletion 30 
mutants identified genes required for cellular damage of and translocation across 31 
enterocytes. Correlation analysis suggests that hypha formation, barrier damage above a 32 
minimum threshold level, and a decreased epithelial integrity are required for efficient 33 
fungal translocation. Translocation occurs predominantly via a transcellular route, which is 34 
associated with fungal-induced necrotic epithelial damage, but not apoptotic cell death. The 35 
cytolytic peptide toxin of C. albicans, Candidalysin, was found to be essential for damage of 36 
enterocytes and was a key factor in subsequent fungal translocation, suggesting that 37 
transcellular translocation of C. albicans through intestinal layers is Candidalysin-mediated. 38 
However, fungal invasion and low-level translocation can also occur via non-transcellular 39 
routes in a Candidalysin-independent manner. This is the first study showing translocation of 40 
a human-pathogenic fungus across the intestinal barrier being mediated by a peptide toxin. 41 
 42 
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Importance 43 
Candida albicans, usually a harmless fungus colonizing human mucosae, can cause lethal 44 
bloodstream infections when it manages to translocate across the intestinal epithelium. This 45 
can result from antibiotic treatment, immune dysfunction or intestinal damage (e.g. during 46 
surgery). However, fungal processes may also contribute. In this study we investigated the 47 
translocation process of C. albicans using in vitro cell culture models. Translocation occurs as 48 
a stepwise process starting with invasion followed by epithelial damage and loss of epithelial 49 
integrity. The ability to secrete Candidalysin, a peptide toxin deriving from the hyphal 50 
protein Ece1, is key: C. albicans hyphae, secreting Candidalysin, take advantage of a necrotic 51 
weakened epithelium to translocate through the intestinal layer. 52 
  53 
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Introduction 54 
Candida albicans is one of the predominant fungal species that colonizes the mucosal 55 
surfaces of most humans as a harmless member of the normal microbiota (1, 2). However, 56 
under certain circumstances, C. albicans can become pathogenic and cause diseases ranging 57 
from common superficial to severe systemic infections (3, 4). These life-threatening 58 
disseminated infections are initiated by endogenous colonizers, which translocate from 59 
mucosal surfaces into the bloodstream. Several studies have demonstrated that the 60 
intestinal population of C. albicans is the main source of disseminated candidiasis (5-11). 61 
However, in a healthy host, the intestinal epithelium, together with mucosal immune cells, 62 
constitute a stable barrier preventing C. albicans from translocating into the bloodstream. 63 
Host defense against translocation is further augmented by the physical barrier functions of 64 
the epithelial layer, with tight junctions and adherens junctions sealing paracellular spaces 65 
(12), and a mucus layer that protects the epithelium, thereby directly affecting C. albicans 66 
physiology and morphology (13). In addition, a balanced and diverse microbiota (14), the 67 
secretion of antimicrobial peptides (AMPs) (15), and the concerted activity of the innate and 68 
adaptive immune system (14, 16) act to reduce hyphal burdens during periods of fungal 69 
overgrowth and restrict the fungus to the commensal (yeast) morphology. However, 70 
dysfunctions in these protective mechanisms can favor C. albicans translocation. 71 
Predisposing conditions that trigger the commensal-to-pathogen shift and translocation of 72 
C. albicans are often iatrogenic. These include an imbalance of the resident microbiota by 73 
use of antibiotics, a compromised immune system (e.g. due to chemotherapy or 74 
immunosuppressive therapy) or damage of epithelial barrier functions by iatrogenic 75 
impairment, for instance due to cytostatic treatment, surgery or trauma (17, 18). 76 
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Consequently, disseminated candidiasis is typically a nosocomial infection and intensive care 77 
unit (ICU) patients are particularly susceptible to invasive C. albicans infections (19-21). 78 
In principle, initiation of disseminated candidiasis requires at least one of four events: (i) 79 
entry of C. albicans cells by direct invasion of epithelial cells (ECs) from intestinal mucosal 80 
surfaces into blood capillaries or vessels; (ii) indirect translocation of C. albicans cells 81 
phagocytosed by host immune cells (“sampling”), (iii) direct damage of mucosal barriers, for 82 
example due to surgery, polytrauma or drug treatment or (iv) spread from fungal biofilms 83 
established on medical devices such as catheters (22, 23). 84 
Translocation of C. albicans in murine models requires a combination of increased fungal 85 
colonization via removal of the bacterial microbiota, neutropenia and intestinal barrier 86 
dysfunction in order to establish disseminated disease (24). Importantly, infrequent fungal 87 
translocation may also occur without epithelial damage under conditions of enhanced fungal 88 
colonization following antibiotic pretreatment (23), and does not always result in systemic 89 
disease in immunocompetent mice (25). 90 
Although dissemination of C. albicans from the intestinal tract has been studied in vivo (5, 91 
24-27), the molecular mechanism of C. albicans translocation across intestinal barriers via 92 
epithelial invasion, and the fungal attributes required for this process are poorly 93 
characterized. Pathogenic interactions of C. albicans with ECs can be divided into three 94 
stages: adhesion, invasion and damage (28-31). Each of these steps requires hypha 95 
formation and the expression of hypha-associated genes. For example, hypha-associated 96 
expression of ALS3 permits not only adhesion (32), but also induced endocytosis (33) and 97 
iron acquisition (34). Expression of ECE1 (encoding the peptide toxin Candidalysin), is 98 
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essential for epithelial damage (35) and is the missing link between hypha formation and 99 
host cell damage (36). 100 
In this study, we used an in vitro translocation model to characterize the events associated 101 
with C. albicans translocation through an intact intestinal barrier. We show that 102 
translocation in this model mainly occurs via a transcellular route associated with fungal-103 
induced necrotic, but not apoptotic cell death. A screen of > 2000 C. albicans gene-deletion 104 
mutants identified several genes associated with intestinal epithelial damage. Selected 105 
damage-defective mutants were analyzed for their impact on epithelial barrier function and 106 
translocation. Our data suggest that C. albicans transcellular translocation through intestinal 107 
layers requires Candidalysin-induced epithelial damage. This is the first study that shows a 108 
peptide toxin-mediated translocation of a human pathogenic fungus. 109 
  110 
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Results 111 
Dynamics of fungal invasion, epithelial damage and loss of epithelial barrier integrity 112 
during translocation of Candida albicans through intestinal epithelial layers 113 
A combination of predisposing factors, including damage to epithelial barriers acquired 114 
during surgery, or polytrauma contribute to disseminated candidiasis. However, 115 
translocation of C. albicans across epithelial barriers can also occur without iatrogenic or 116 
accidental epithelial damage. We hypothesized that this particular type of translocation from 117 
the gut into the bloodstream requires invasion into intestinal ECs (IECs) that is associated 118 
with fungal-induced cellular damage and loss of epithelial barrier integrity. To investigate the 119 
dynamics of this process, we established a translocation assay using the C2BBe1 cell line, a 120 
sub-clone of the human intestinal cell line Caco-2 (37), in a trans-well system, by modifying 121 
previous protocols (29, 38, 39). We infected C2BBe1 enterocytes with Wild type (Wt) 122 
C. albicans and monitored fungal invasion (via differential staining), host cell damage (via 123 
release of epithelial lactate dehydrogenase (LDH)), loss of epithelial monolayer integrity (via 124 
quantification of TEER (transepithelial electrical resistance)) and translocation (via fungal 125 
burdens) (Figure 1). 126 
Low-level invasion (3.6%) of C. albicans into C2BBe1 cells was observed 3 h post infection 127 
(p.i.) and steadily increased over time (Figure 1A, B). The observed invasion did not correlate 128 
with a loss of epithelial barrier integrity, epithelial damage or translocation during the early 129 
stages (< 3 h) of infection (Figure 1C, D). However, extensive epithelial damage, loss of 130 
barrier integrity and translocation were observed between 8 h and 30 h p.i. (Figure 1C, D). 131 
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Previous studies have shown that invasion of C. albicans into differentiated enterocytes 132 
(Caco-2) is a hypha-dependent, fungal-driven process that occurs via active penetration, but 133 
not induced endocytosis, in contrast to other epithelial cells  such as oral ECs (29, 40). To 134 
investigate whether the same was also true for the invasion of C. albicans into the C2BBe1 135 
subclone, differentiated C2BBe1 cells were treated with the actin polymerization inhibitor 136 
Cytochalasin D which blocks induced endocytosis. Cytochalasin D did not impair invasion of 137 
C. albicans into C2BBe1 cells, and UV-killed hyphae, which are endocytosed by oral ECs (29), 138 
were not endocytosed by C2BBe1 cells (Figure S1). Therefore, invasion into differentiated 139 
C2BBe1 intestinal cells is a fungal-driven process. 140 
Large-scale screening of C. albicans mutant libraries identifies genes important for 141 
epithelial damage 142 
Since in vitro translocation of C. albicans correlated with cytotoxicity, we investigated 143 
whether C. albicans factors necessary for damage of IECs might also play a role in fungal 144 
translocation. Therefore, we screened three C. albicans gene deletion mutant libraries (41-145 
43) for their ability to damage Caco-2 IECs by quantifying LDH levels. A total of 2034 146 
C. albicans gene-deletion mutants were screened including 1165 homozygous ORF deletions 147 
(approximately 20% of all annotated C. albicans genes (Data Set S1)). These included genes 148 
required for a broad spectrum of biological processes and potential virulence-associated 149 
traits (41), including transcriptional regulators (43). In total, we identified 172 C. albicans 150 
gene-deletion mutants that caused significantly less damage (< µ-2σ) when compared to 151 
their respective Wt control (Data Set S1 in red, Data Set S2). In silico gene ontology (GO) 152 
term analysis revealed that these genes are putatively involved in filamentation, 153 
pathogenesis and stress responses (among other functions; Figure 2A). The Candida Genome 154 
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Database (44) identified 67 of these genes as having unknown function (Data Set S2, in blue). 155 
We also identified 102 C. albicans gene-deletion mutants that caused more damage (> µ+2σ) 156 
to Caco-2 IECs when compared to the Wt (Data Set S1 in green, Data Set S2). In silico analysis 157 
of the corresponding genes of this subgroup showed putative associations with biofilm 158 
formation and cell surface composition (among other functions; Figure 2B). Fifty-two of 159 
these genes encode proteins with unknown function (Data Set S2 in blue). 160 
The cytotoxicity analysis was performed in parallel with general growth assays in YPD broth 161 
and morphology analysis on IECs (Data Set S2). C. albicans gene-deletion mutants with a 162 
general growth defect in complete medium and mutants with severe morphological defects 163 
were excluded from further analysis, since such phenotypes were expected to lead to 164 
unspecific or morphology-related reductions in damage. Indeed, the majority of gene-165 
deletion mutants that were compromised for hypha formation were also severely 166 
attenuated in their ability to cause damage (Data Set S2). Of the 172 gene-deletion mutants 167 
identified that were hypo-damaging to Caco-2 IECs, 38 mutants with no obvious growth or 168 
filamentation defects were selected for further analysis in epithelial damage assays using 169 
differentiated C2BBe1 cells (Data Set S2 in orange).  170 
Based on these data, nine genes were selected for further analysis: PRN4, orf19.2797, NPR2, 171 
AAF1, HMA1, TEA1, orf19.3335, PEP12 and ECE1 (Table S1). Selection criteria included (a) 172 
previously uncharacterized genes (PRN4, NPR2, orf19.2797, HMA1, TEA1, orf19.3335), (b) 173 
genes uncharacterized for interaction with IECs (AAF1, PEP12, ECE1) (35, 45-47) and/or (c) 174 
genes with putative functions including urea transport, transcriptional regulation, ligand 175 
binding and cytolytic toxicity (Table S2). 176 
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Since it is frequently observed that the altered phenotypes of mutants identified in the 177 
screen were not due to targeted gene-deletion, but rather unspecific genomic alterations, 178 
and to exclude differences between genetic backgrounds, all nine selected mutants were 179 
recreated in a BWP17 genetic background (48). These mutants were characterized in more 180 
detail (below), including quantification of their hyphal length, adhesion, invasion potential 181 
and damage (Figure 3 and S2). All mutants were significantly impaired in their ability to 182 
cause damage to differentiated C2BBe1 cells 24 h p.i., quantified by LDH measurements 183 
(Figure 3A), with the exception of the prn4Δ/Δ mutant, which exhibited Wt levels of damage 184 
and was thus not further investigated. The degree of damage reduction varied from 185 
moderate (less than 50%: npr2Δ/Δ, orf19.2797Δ/Δ, aaf1Δ/Δ and hma1Δ/Δ) to severe (more 186 
than 50%: tea1Δ/Δ, orf19.3335Δ/Δ, pep12Δ/Δ and ece1Δ/Δ). Interestingly, almost every 187 
mutant showed a unique pattern of phenotypic defects potentially responsible for the 188 
reduced damage observed (Figure 3). For example, invasion of IECs by the aaf1Δ/Δ and 189 
pep12Δ/Δ mutants was significantly reduced, the pep12Δ/Δ mutant had significantly shorter 190 
hyphae when compared to Wt, while the hma1Δ/Δ and orf19.3335Δ/Δ mutants showed 191 
moderately reduced adhesion, invasion and hyphal length. In contrast, the ece1Δ/Δ mutant 192 
did not show any obvious phenotypic alteration except reduced damage (Figure 3C, D; Figure 193 
S2). 194 
Translocation of C. albicans through enterocytes is associated with damage and loss of 195 
epithelial barrier integrity 196 
Our initial experiments demonstrate that translocation of C. albicans through the intestinal 197 
layer is associated with cellular damage and loss of epithelial integrity (Figure 1). 198 
Accordingly, we tested whether decreased levels of epithelial damage were associated with 199 
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a lower level of epithelial translocation. Further, we compared the ability of a "normal"-200 
damaging mutant (bas1Δ/Δ) and a hyper-damaging mutant (snt1Δ/Δ; Data Set S1 in green, 201 
Data Set S2) to translocate across an epithelial barrier. Several well characterized control 202 
strains were included in this analysis, including mutants lacking genes involved in hypha 203 
morphogenesis, hyphal maintenance, biofilm formation, adhesion, protein processing or 204 
secreted protease activity (Table S2). Furthermore, translocation through a blank insert in 205 
the absence of an EC layer was quantified to exclude translocation impairment independent 206 
of host cells (see Methods; Figure S3A). 207 
Figure 4 summarizes epithelial damage, fungal translocation and epithelial integrity data of 208 
all 19 mutants. To identify correlations between mutant phenotypes and the ability to 209 
translocate through epithelial layers, and thus to identify properties associated with 210 
C. albicans translocation, we used a bioinformatics approach. First, we applied a density-211 
based spatial clustering with noise (DBSCAN) algorithm (49) to categorize C. albicans 212 
mutants into groups with similar behavior based on the three parameters “epithelial 213 
damage”, “epithelial integrity” and “fungal translocation” (Figure 4 and S4). This lead to the 214 
arrangement of strains in three clusters, with cluster I strains showing low damage, low 215 
translocation rates and almost unaltered TEER values; cluster II strains being similar to the 216 
wild type and cluster III strains displaying low damage and translocation, but wild type like 217 
loss of TEER. However, some C. albicans mutants could not be assigned to any cluster and 218 
were unique in their behavior in the translocation model. Interestingly, the snt1Δ/Δ mutant, 219 
a member of the hyper-damaging group was significantly attenuated in causing loss of 220 
epithelial integrity and translocation through epithelial layers, whereas the hypha-deficient 221 
hgc1Δ/Δ mutant caused significantly reduced damage, but could still translocate, while 222 
epithelial integrity was reduced by approximately 50%. An ece1Δ/Δ mutant displayed a 223 
13 
 
moderate loss of epithelial integrity (50%) compared to Wt, but caused almost no damage 224 
and exhibited a 75% reduction in translocation. Finally, the unassigned Sap mutants sap1-225 
3Δ/Δ and sap4-6Δ/Δ showed a very strong similarity to cluster II, except for increased 226 
translocation potential, which was related to an altered ability to cross a blank transwell 227 
insert (Figure S3A). 228 
Based on these observations, a bioinformatic analysis was performed between pairings of 229 
the three parameters; “epithelial damage”, “epithelial integrity” and “fungal translocation” 230 
to understand their reciprocal relationship. According to Pearson’s correlation analysis, all 231 
three parameters were significantly correlated, while according to Spearman’s correlation 232 
analysis, translocation and epithelial integrity (TEER) were not significantly correlated (Figure 233 
5). Both types of correlations were of moderate magnitude ±0.5, which is explained by the 234 
strong variability among strains. For example, although translocation generally increases 235 
with increased epithelial damage (LDH), the mutant snt1Δ/Δ displays reduced translocation, 236 
even though it has the highest epithelial damage of all mutants. Next, to quantify any non-237 
linear behaviors in the correlations, we fitted a first-order polynomial and an exponential 238 
function of the form 𝑦 = 𝐴𝑒−𝛼𝑥 + 𝐵 to each pair of measurements and evaluated the most 239 
appropriate model using the Bayesian Information Criterion (BIC (50)). In Figure 5A, we 240 
plotted the fitted polynomials and the LOWESS line ((51) i.e. a non-parametric smoothing 241 
that visualizes overall trends in noisy data) and provided the BIC values in Figure 5A and 5B. 242 
For epithelial damage and translocation, there was no improvement in the BIC using the 243 
exponential fit compared to a first-order polynomial, and the latter was observed to be close 244 
to the LOWESS line. This indicated a close-to-linear relationship between damage and 245 
translocation, suggesting that these two outcomes are most often the result of the same or 246 
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closely related processes. For epithelial damage and integrity, the LOWESS line and the 247 
exponential function tracked closely with another, which coincides with a considerable 248 
decrease in the BIC. This indicates that in the presence of epithelial damage, the epithelial 249 
integrity decreases rapidly to a minimum, independent of additional damage being induced. 250 
Lastly, translocation and epithelial integrity show the lowest correlation with a small 251 
improvement in BIC values using an exponential function. The increase is not as large as for 252 
epithelial damage and integrity and the clear deviation from the LOWESS line indicates that 253 
neither function is able to track the structure of the data very well. The lack of significance in 254 
Spearman’s correlation coefficient can be explained by the structure of the data as seen in 255 
Figure 5A. For strains with high translocation (> 90% of Wt) the epithelial integrity is 256 
constantly low, i.e. around Wt levels (100% TEER loss), while for low translocation values (0-257 
40% of Wt) there is no clear structure in the epithelial integrity data. Pearson’s correlation 258 
coefficient takes into account that very high translocation indicates low epithelial integrity, 259 
while the non-significant Spearman’s correlation coefficient captures the lack of correlations 260 
within strains with low and high translocation. This reveals that while decreased epithelial 261 
integrity is a prerequisite for translocation, this does not predict fungal translocation (i.e. as 262 
seen with pep12Δ/Δ (Figure 4)). 263 
Dissecting the potential routes of C. albicans translocation through enterocyte layers 264 
Our data and bioinformatic analyses suggest that while epithelial damage and loss of 265 
epithelial integrity are associated with translocation of C. albicans through epithelial 266 
barriers, this does not always predict the amount of fungal translocation. These analyses 267 
suggest two basic routes of gut translocation by C. albicans: paracellular (between adjacent 268 
IECs) and transcellular (through viable or non-viable enterocytes from the apical to the 269 
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basolateral side) (Figure 6AI-III). The latter would potentially be associated with EC death, 270 
which could either be necrotic or apoptotic. 271 
Next, we investigated the role of epithelial apoptosis versus necrosis for transcellular 272 
translocation (Figure 6). The contribution of enterocyte apoptosis following C. albicans 273 
infection was monitored by Annexin V staining and fluorescence microscopy, as well as 274 
Caspase 3/7 activity assays. We found that C. albicans does not induce apoptosis in C2BBe1 275 
cells, even 24 h p.i. (Figure 6B-D). In contrast, approximately 40% of IECs exhibited necrotic 276 
cell death 24 h p.i. in response to C. albicans, as indicated by ethidium homodimer III (EthD-277 
III) staining (Figure 6C). Therefore, necrotic cell death appears to be the major mechanism 278 
supporting C. albicans transcellular translocation in our model (Figure 1, 3, 6). 279 
Candidalysin is critical for intestinal epithelial damage and fungal translocation  280 
The secretion of the cytolytic peptide toxin Candidalysin, encoded by the ECE1 gene, is 281 
known to be critical for oral and vaginal EC damage (35, 52). Given that necrotic cell death 282 
appears to be the major mechanism supporting C. albicans transcellular translocation, we 283 
investigated the role of Candidalysin in gut translocation in our in vitro model. We found that 284 
a C. albicans strain lacking ECE1 was hypo-damaging to IECs, was unable to translocate 285 
across the gut barrier, and was defective in reducing epithelial integrity (Figure 3, 4).  286 
To confirm that Candidalysin was required for intestinal cell damage, we infected C2BBe1 287 
cells with either a C. albicans mutant that lacked only the Candidalysin-encoding region 288 
within ECE1 (ece1∆/∆+ECE1∆184-279) or with synthetic Candidalysin toxin (35). Both the 289 
ece1Δ/Δ and ece1∆/∆+ECE1∆184-279 mutants exhibited normal adhesion, epithelial invasion 290 
and hyphal growth (Figure 7A, B, C) but were unable to induce epithelial damage (Figure 7D), 291 
in contrast to the Wt strain and a revertant strain expressing one Wt copy of ECE1 292 
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(ece1Δ/Δ+ECE1). Interestingly, the addition of synthetic Candidalysin to IECs caused only 293 
minimal damage (Figure 7). However, combined administration of Candidalysin with ece1Δ/Δ 294 
and ece1∆/∆+ECE1∆184-279 partially restored the damage capacity of these strains (Figure 7D). 295 
This demonstrates that a combination of hypha formation and Candidalysin secretion is 296 
required for optimal damage induction of IECs by C. albicans. 297 
Next, we investigated the influence of Candidalysin on intestinal barrier integrity by 298 
monitoring TEER and quantifying the diffusion of 4 kDa dextran-polymers (Figure 7E, G). The 299 
TEER values of C2BBe1 epithelium infected with Wt C. albicans or an ece1Δ/Δ mutant 300 
constantly dropped over a time period of 48 h, but there was retention of TEER for the 301 
ece1Δ/Δ and ece1∆/∆+ECE1∆184-279 mutant between 24-32 h p.i. (Figure 7G). Accordingly, the 302 
dextran diffusion assay showed reduced barrier leakage in response to infection with the 303 
ece1Δ/Δ and ece1∆/∆+ECE1∆184-279 mutant (Figure 7E). In contrast to the damage assay, 304 
addition of synthetic Candidalysin to C2BBe1 epithelium had no direct (single administration) 305 
or indirect (administration together with ece1Δ/Δ or ece1∆/∆+ECE1∆184-279) effect on 306 
epithelial barrier function (Figure 7E, G). As a means of comparison, we also administered 307 
melittin, a cytolytic peptide toxin in bee venom, as a positive control (53) in the damage and 308 
barrier integrity assays. Melittin caused high LDH release (Figure 7D) and completely 309 
abolished epithelial barrier function (Figure 7E, G). 310 
As an expected consequence of reduced EC damage and reduced loss of integrity, 311 
translocation of ece1Δ/Δ and ece1∆/∆+ECE1∆184-279 was significantly reduced. We observed a 312 
trend towards higher translocation of ece1Δ/Δ and ece1∆/∆+ECE1∆184-279 mutants when 313 
Candidalysin was added during epithelial infection (Figure 7F). Of note, while damage was 314 
almost abolished in the absence of Candidalysin or ECE1, translocation of the respective 315 
mutants was still possible to a limited extent (approximately 25% of Wt) (Figure 4 and 7), 316 
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emphasizing that translocation can occur without damage and independently of 317 
Candidalysin. Therefore, we proposed a second route of transcellular translocation, which is 318 
not associated with EC damage (Figure 6A IV). In this scenario hyphae would invade ECs on 319 
the apical side and emerge on the basolateral side without causing host membrane damage 320 
and without causing release of cellular content (Figure 6A IV). Fluorescence microscopy 321 
pictures clearly demonstrate that the hyphae of an ece1Δ/Δ mutant can invade and grow 322 
through IECs (Figure 6E) without causing epithelial damage (Figure 7D). Furthermore, 323 
transmission electron microscopy (TEM) pictures of invasive C. albicans hyphae show the 324 
presence of a host membrane surrounding hyphae in some pictures (Figure 6F, black 325 
arrows), suggesting that transcellular translocation without membrane damage may be 326 
possible. 327 
In conclusion, our data show that C. albicans is able to translocate through intact intestinal 328 
epithelial barriers predominantly via a damage-associated necrotic, but not apoptotic, 329 
transcellular route. Disturbance of epithelial integrity, cellular damage and transcellular 330 
translocation requires a combination of fungal properties, including hypha formation and 331 
the secretion of Candidalysin. 332 
Discussion 333 
The human gastrointestinal tract is colonized by a dense population of microorganisms, 334 
including bacteria and fungi. Although the gut epithelial layers and associated immune cells 335 
provide a functional barrier between these microbes and the host, microbial translocation is 336 
frequent, even in healthy individuals (54). However, in critically ill patients, translocation 337 
may lead to life-threatening infections. Several studies ascribe the major source of systemic 338 
candidiasis to the commensal C. albicans population of the human intestinal tract (8, 10, 55). 339 
18 
 
However, we know little about how C. albicans translocates across intact intestinal epithelial 340 
barriers. In this study, we used an in vitro model and a reductionist approach to identify the 341 
C. albicans factors and host mechanisms involved in fungal translocation across the human 342 
gut barrier. While previous studies have focused on either C. albicans translocation (29, 38), 343 
C. albicans-dependent epithelial damage (29, 39), or epithelial integrity (39), our study 344 
analyzed all three processes over time to identify the fungal factors and host mechanisms 345 
associated with C. albicans translocation across the intact gut barrier. We demonstrate that 346 
C. albicans translocation is a dynamic fungal-driven process initiated by invasion (active 347 
penetration), and followed by cellular damage and loss of epithelial integrity. Experimental 348 
and bioinformatic correlation analyses indicated that epithelial damage and loss of epithelial 349 
integrity closely correlated with C. albicans translocation. Translocation occurs via a 350 
transcellular route, which is associated with fungal-induced necrotic epithelial damage, 351 
driven by the cytolytic peptide toxin Candidalysin. However, fungal invasion and low-level 352 
translocation can also occur in a Candidalysin-independent manner. 353 
To identify fungal factors involved in C. albicans gut translocation, we screened > 2000 354 
C. albicans gene-deletion mutants. We identified 172 gene-deletion mutants that were 355 
hypo-damaging, including 38 mutants with no obvious growth or filamentation defects. Of 356 
these, eight mutants were selected for further analyses and subsequently found to have 357 
defects in adhesion, invasion and hyphal length, or potential defects in transcriptional and 358 
cellular regulation or protein trafficking (45-47). The main exception was a C. albicans ECE1 359 
gene-deletion mutant, which had normal hypha formation/length, adhesion to and invasion 360 
of IECs, but was defective in inducing epithelial damage. Interestingly, C. albicans ECE1 361 
encodes a cytolytic peptide toxin, Candidalysin, which is critical for mucosal infections (35, 362 
36). 363 
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Next, using a larger panel of C. albicans mutants we determined that hypha formation was a 364 
key fungal attribute that promoted epithelial damage, loss of epithelial integrity and 365 
translocation. However, translocation was not dependent upon hypha formation, as some 366 
mutants (e.g. hgc1Δ/Δ (56)), which are generally yeast-locked or do not maintain hyphae, 367 
were still able to translocate across intestinal cells to a limited degree. Notably, though, 368 
hgc1Δ/Δ still expressed hypha-associated genes, including ECE1 (data not shown), again 369 
potentially linking Candidalysin to gut translocation. These findings may also explain 370 
contrasting data from in vivo translocation experiments, in which C. albicans gut 371 
translocation was shown to be both hypha-dependent (24) and –independent (25). Other 372 
proteins that contributed to C. albicans damage and translocation included Kex1, a Golgi 373 
protease involved in the processing of Candidalysin (35, 57) and Als3, a GPI-anchored 374 
adhesin and invasin that is the main trigger of induced endocytosis for certain types of 375 
epithelial and endothelial cells (33, 58). The als3Δ/Δ mutant had strong defects in damage, 376 
translocation and disruption of epithelial integrity. However, since invasion into IECs occurs 377 
independently of induced endocytosis (29), we concluded that the observed phenotypes 378 
were mostly due to the severely reduced adhesion of this mutant (58) rather than direct 379 
action of Als3 on the gut barrier. 380 
Our experimental findings were supported by bioinformatic approaches that also indicated a 381 
correlation between damage of IECs and translocation. Interestingly, a cluster of C. albicans 382 
mutants was identified with reduced epithelial damage but normal fungal translocation 383 
(Figure 4, Cluster II), indicating that only a certain level of damage induction is required to 384 
achieve efficient translocation. Furthermore, fungal translocation was not observed without 385 
reduction in TEER, strongly suggesting that disturbance of epithelial integrity is a 386 
prerequisite for translocation. However, a decrease of epithelial integrity does not 387 
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necessarily lead to significant fungal translocation (as observed for pep12Δ/Δ and 388 
orf19.3335Δ/Δ). Hence, TEER loss is necessary, but not sufficient to cause fungal 389 
translocation. Thus, in agreement with Böhringer et al. (39), we propose that damage and 390 
destruction of epithelial integrity can be independent processes, and that loss of epithelial 391 
integrity may be caused by necrotic cell damage (59) or opening of cell-cell connections (e.g. 392 
tight junctions). Epithelial damage and reduction of barrier integrity are likely coupled during 393 
necrosis, but loss of epithelial integrity can occur independently of necrosis. 394 
One of the most intriguing findings of the study was the discovery that the hypha-associated 395 
peptide toxin, Candidalysin, appears to be a crucial factor in mediating intestinal epithelial 396 
damage and fungal translocation. Notably, the combination of exogenous addition of 397 
Candidalysin to an ECE1-deficient strain only partially restored Wt damage and translocation 398 
levels and the exogenous addition of Candidalysin alone had only spare effects (Figure 7). 399 
Several studies, including Moyes et al. (35), proposed a membrane-bound ‘invasion pocket’ 400 
during hyphal invasion of epithelial cells (29, 60, 61) which was further verified for the 401 
C2BBe1 cells in this study (Figure 6F). This invagination of the epithelial membrane at the 402 
site of hyphal invasion  results in a close contact of the fungus to host membranes and 403 
should allow an accumulation of Candidalysin that may be required for full damage potential 404 
and subsequent translocation. Therefore, the exogenous addition of Candidalysin probably 405 
does not fully mimic the natural secretion by hyphae within this invasion pocket and thus 406 
does not fully restore Wt damage levels. It is less likely that the other non-Candidalysin Ece1 407 
peptides play a role in this setting, since when adding such peptides together with 408 
Candidalysin, no increased damage was observed (data not shown); along the same line, 409 
adding Candidalysin to a Candidalysin-deficient strain (ece1∆/∆+ECE1∆184-279), also only 410 
partially restored Wt damage and translocation levels. 411 
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However, we noted that while the ece1Δ/Δ mutant was unable to damage ECs, it was still 412 
able to lower epithelial integrity and translocate across the intestinal barrier to some extent. 413 
This suggests that damage-independent fungal factor(s) can also modulate epithelial 414 
integrity. Such factor(s) probably contribute to the paracellular route of translocation by 415 
degrading cell-cell connections such as tight junctions or adherens junctions. Possible 416 
candidates contributing to the paracellular route of translocation are the secreted aspartic 417 
proteases (Saps), which may promote degradation of the adherens junction protein E-418 
cadherin (29, 62, 63). However, we found that mutants lacking different SAP genes (sap1-419 
3Δ/Δ, sap5Δ/Δ, sap4-6Δ/Δ, sap9/10Δ/Δ) had no translocation defects. This is with the caveat 420 
that the sap1-3Δ/Δ mutant exhibited reduced translocation through blank transwell inserts 421 
(without C2BBe1 cells), and thus we cannot exclude a minor role for Saps in the paracellular 422 
route of translocation. In summary, our data demonstrate that C. albicans translocates 423 
across the intestinal epithelial barrier predominantly via the transcellular route, which 424 
requires hypha formation, active penetration (not induced endocytosis), Candidalysin-425 
induced epithelial damage and cellular necrosis. However, C. albicans can also translocate 426 
via the paracellular route in a damage- and Candidalysin-independent manner via currently 427 
unknown mechanisms. 428 
While our in vitro data are likely to be reflective of the C. albicans translocation process in 429 
vivo, host-driven uptake and fungal translocation in vivo may also occur via specialized 430 
intestinal cells, in particular M-cells associated with Peyer’s Patches, which were not 431 
modelled into our assays. M-cells are capable of endocytosing C. albicans (64) and are 432 
targeted by several pathogenic gram-negative bacteria including Shigella, Salmonella, and 433 
Yersinia spp. (65-67). Nevertheless, our study indicates that efficient C. albicans 434 
translocation can also occur in the absence of M-cells, predominantly via Candidalysin-435 
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mediated necrotic damage to the intestinal barrier. With this in mind, toxin-induced 436 
intestinal barrier dysfunction is also an important factor contributing to the pathogenicity 437 
of enteric bacteria. Clostridium perfringens produces a number of toxins that impairs 438 
intestinal barrier function. These include C. perfringens δ-toxin, a β-pore-forming-toxin, 439 
which is cytotoxic to Caco-2 cells and functions to reduce epithelial integrity (TEER) and 440 
increase permeability without altering tight junctions (68). In contrast, 441 
C. perfringens enterotoxin (CPE) directly attaches to and disintegrates tight junctions 442 
(claudin family), resulting in an increase in paracellular permeability across the epithelial 443 
barrier (69). Furthermore, the phospholipase C activity of C. perfringens α-toxin results in 444 
increased gut permeability, most likely due to the redistribution and/or degradation of 445 
tight junction proteins (70). Likewise, Suilysin, a cholesterol-dependent cytolysin produced 446 
by the swine pathogen Streptococcus suis, is thought to promote bacterial translocation via 447 
epithelial damage induction, although the precise mechanisms are unclear (71). While many 448 
other bacteria are capable of translocating across the gut barrier, such as enteropathogenic 449 
Escherichia coli (EPEC), Campylobacter jejuni and Salmonella typhimurium, the 450 
mechanisms by which this occurs may not always be attributed to the function of toxins (72). 451 
Irrespective, the majority of enteric bacteria appear to translocate via the paracellular route 452 
rather than transcellular route. 453 
In summary, C. albicans translocation predominantly occurs via a transcellular route, 454 
associated with Candidalysin-induced necrotic epithelial damage. However, invasion and 455 
low-level translocation can also occur in a Candidalysin-independent manner, most likely via 456 
a paracellular route. 457 
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Methods 458 
Candida albicans strains and growth conditions 459 
All strains used in this study are listed in Table S1. C. albicans strains were routinely grown 460 
on YPD broth/agar (1% yeast extract, 2% peptone, 2% glucose, ± 1.5% agar) at 30°C. For all 461 
experiments, C. albicans cells were cultured overnight in YPD broth at 30°C, shaking at 462 
180 rpm. Cells from overnight cultures were collected by centrifugation, washed twice with 463 
PBS, and the number of cells adjusted as indicated. 464 
Generation of C. albicans mutant strains 465 
Gene deletions were performed as previously described (48). Deletion cassettes were 466 
generated by PCR by amplifying pFA-HIS1 and pFA-ARG4–based markers with respective 467 
primers for the gene to be deleted (Data Set S3). C. albicans BWP17 was sequentially 468 
transformed with the generated deletion cassettes and then transformed with CIp10 (73). All 469 
integrations were confirmed by PCR/sequencing. As exception, the mutants sap1-3Δ/Δ and 470 
sap4-6Δ/Δ were created with the Ura-blaster method (74-76).  471 
Culture and maintenance of IEC lines 472 
The intestinal epithelial Caco-2 subclone C2BBe1 (Caco-2 brush border expressing 1, 473 
ATCC®CRL2102™; (37)) was routinely cultivated in DMEM (ThermoFisher Scientific) 474 
supplemented with 10% fetal calf serum (FCS, Bio&Sell) and 10 µg/mL Holotransferrin 475 
(Calbiochem Merck) in a humidified incubator at 37°C, 5% CO2. C2BBe1 cells were seeded in 476 
collagen I-coated wells (10 µg/mL collagen I for 2 h at room temperature (RT); ThermoFisher 477 
Scientific). Transwell inserts (polycarbonate membrane with 5 µm pores; Corning) and 96-478 
well plates were seeded with 2×104 cells/well or insert and glass cover slips placed in 24-well 479 
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plates with 1×105 cells/well. C2BBe1 cells were cultured for 14 days for differentiation, with 480 
medium exchanged every 3-4 days. 481 
The IEC line Caco-2 (ACC 169 from DSMZ) was cultivated in DMEM medium supplemented 482 
with 10% FCS and 1% NEAA (MEM non-essential amino acids, Biochrom AG), for 2 days. All 483 
infections were performed in serum-free DMEM in a humidified incubator at 37°C and 5% 484 
CO2. This cell line was used only for the large scale mutant screening (see ‘C. albicans large 485 
scale mutant screening’). For this purpose, Caco-2 cells were seeded in 96-well plates with 486 
2×104 cells/well and grown over two days to confluency. 487 
C. albicans large scale mutant screening 488 
C. albicans strains were cultivated in YPD broth in 96-well plates and incubated for 24 h at 489 
30°C, 180 rpm. Next day, a 1:20 subculture was set up in fresh YPD and incubated overnight 490 
at 30°C, 180 rpm. Cultures were then diluted 1:10 in PBS. From this dilution, a 1:20 dilution 491 
in YPD was used to analyze growth at 30°C (see section ‘Analysis of fungal growth’) and a 492 
1:20 dilution in serum-free DMEM was used to infect confluent Caco-2 cells. After 24 h of 493 
infection, damage was evaluated by quantifying the release of cytoplasmatic lactate 494 
dehydrogenase (LDH) (see section ‘Quantification of cytotoxicity (LDH assay)’). In the large-495 
scale mutant screening for damage, all values were compared to an uninfected control 496 
treated with 0.25 % Triton-X-100 to obtain full lysis of the Caco-2 cells and mutant values 497 
outside the 2σ range of the Wt were considered significantly different. 498 
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Analysis of fungal growth 499 
Fungal growth was analyzed in 96-well plates in YPD broth. Respective C. albicans strains 500 
were added to a final count of 4×105 cells/well. Growth was followed by measuring the 501 
absorbance at 600 nm every 30 min for 2 days at 30°C in a microplate reader (Tecan). 502 
Quantification of adhesion, invasion and hypha length 503 
C. albicans cells were added to 14 day old C2BBe1 cells in 24-well plates to a final 504 
concentration of 1×105 cells/well for adhesion assays and 5×104 cells/well for invasion and 505 
hypha length assays. Control experiments for hypha length were done the same way on 506 
plastic without C2BBe1. 507 
Adhesion of C. albicans to ECs was determined 1 h post-infection (p.i.). Non-attached 508 
C. albicans cells were removed by washing 3× with PBS. Samples were fixed with Histofix 509 
(Roth) for 15 min at RT or overnight at 4°C and subsequently rinsed 3× with PBS. Adherent 510 
fungi were stained with Calcofluor White (10 µg/mL in 0.1 M Tris-HCl, pH 9.0, Sigma-Aldrich) 511 
for 20 min at RT in the dark. After washing 3× with water, samples were mounted on glass 512 
slides with ProLong mountant (ThermoFisher Scientific) and analyzed by fluorescence 513 
microscopy. The number of adherent C. albicans cells was determined in about 100 random 514 
fields of a defined size (200x200 µm). Assuming an even distribution of Candida cells, the 515 
total amount of adherent cells on the entire cover slip was calculated based on the number 516 
counted in the defined area. This number was expressed as percentage of adhered cells 517 
versus inoculated C. albicans cells (also see (29, 58).Invasion of C. albicans into differentiated 518 
C2BBe1 cells was analyzed by differential staining according to (58, 77) with the following 519 
minor modifications. Briefly, after 5 h of C. albicans infection, C2BBe1 cells were washed 3× 520 
with PBS and fixed with Histofix. Extracellular, non-invasive fungal components were stained 521 
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by incubating with a primary antibody against C. albicans (1:2000 in PBS, rabbit anti-Candida 522 
BP1006, Acris antibodies) for 1 h at 30°C, washing 3× with PBS and incubating with a 523 
secondary antibody (1:5000 in PBS, goat-anti-rabbit-AlexaFluor488 A-11008, ThermoFisher 524 
Scientific) for 1 h at 30°C. After rinsing 3× with PBS, ECs were permeabilized with 0.5% 525 
Triton-X-100 for 10 min at RT and washed again 3× with PBS. The actin cytoskeleton was 526 
stained with Phalloidin-AlexaFluor594 (1:50 in PBS, A12381, ThermoFisher Scientific) for 1 h 527 
at 30°C. After washing again 3× with PBS, C. albicans cells were stained with Calcofluor 528 
White as described above. After mounting, samples were visualized by fluorescence 529 
microscopy. The percentage of invasive C. albicans hyphae (only Calcofluor White stained) 530 
was counted from at least 100 hyphae per strain in at least three independent experiments. 531 
The total hypha length was also recorded. For invasion experiments with Cytochalasin D 532 
(Sigma-Aldrich), 1 µL of Cytochalasin D or DMSO (as solvent control) was added, to a final 533 
concentration of 0.5 µM, 45 min prior to infection (78). 534 
Quantification of cytotoxicity (LDH assay) 535 
Differentiated C2BBe1 cells in 96-well plates were infected for a defined time period with 536 
8×104 C. albicans cells/well, or with Candidalysin toxin (Sequence: 537 
SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK, Proteogenix / Peptide Protein Research Ltd) prepared 538 
in water and added to the desired final concentration. After co-incubation, epithelial 539 
damage was quantified by measuring LDH release using a Cytotoxicity Detection Kit (Roche) 540 
according to the manufacturer’s instructions. LDH isolated from rabbit muscle (Roche) was 541 
used to generate a standard curve. The background LDH value of uninfected C2BBe1 cells 542 
was subtracted and the corrected LDH release was expressed as % Wt unless otherwise 543 
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stated. Cytotoxicity analysis was performed in triplicate and finally determined from at least 544 
three independent experiments. 545 
In vitro translocation model 546 
Differentiated C2BBe1 cells grown in transwell inserts (Figure S5) were infected with 1×105 547 
C. albicans cells per transwell and/or Candidalysin toxin for 24 h. Before and after 548 
incubation, TEER values were measured using a Voltohmmeter (WPI). The resistance of a 549 
blank insert (≈120 Ω) was subtracted from each value. The absolute TEER loss (in Ω) of the 550 
respective Wt was set as 100% and the TEER loss of the mutant strains were expressed in 551 
percentage of the Wt. After 24 h of infection, Zymolyase (Amsbio) was added to the 552 
basolateral chamber to a final concentration of 20 U/mL and incubated for 2 h at 37°C and 553 
5% CO2. Afterwards, detached C. albicans hyphae were collected and plated onto YPD agar. 554 
Translocation was measured in triplicate in at least three independent experiments. Each 555 
C. albicans mutant was additionally tested for general growth, sensitivity against Zymolyase 556 
and translocation independent of C2BBe1 (through a blank insert). 557 
To test for abnormal sensitivity towards Zymolyase treatment, C. albicans strains were 558 
placed in a 96-well plate (1×105 cells/well) in serum-free DMEM. After incubation for 3 h at 559 
37°C and 5% CO2, Zymolyase was added to a final concentration of 20 U/mL. Cells were 560 
incubated for 2 h, diluted in PBS and plated onto YPD agar. Colonies were counted after 561 
2 days and compared to the respective Wt. 562 
The translocation rate of C. albicans strains through blank, collagen I-coated transwell inserts 563 
was measured as indicated above. However, C. albicans strains were incubated in DMEM at 564 
37°C and 5% CO2 for 3 h before addition to the inserts, to induce filamentation and to reduce 565 
unspecific translocation of yeast cells. Blank translocation was used to correct the 566 
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translocation rate through C2BBe1 cells. For each mutant, the efficiency of fungal 567 
translocation was calculated for each biological replicate as follows: 568 
% 𝑇𝑟𝑎𝑛𝑠𝑙𝑜𝑐𝑎𝑡𝑖𝑜𝑛 (𝑇𝐿) 𝑣𝑠. 𝑤𝑖𝑙𝑑𝑡𝑦𝑝𝑒 (𝑊𝑡) =  
𝑇𝐿 𝑜𝑓 𝑚𝑢𝑡𝑎𝑛𝑡
𝑇𝐿 𝑜𝑓 𝑊𝑡
∗
𝑏𝑙𝑎𝑛𝑘 𝑇𝐿 𝑜𝑓 𝑊𝑡̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅
𝑏𝑙𝑎𝑛𝑘 𝑇𝐿 𝑜𝑓 𝑚𝑢𝑡𝑎𝑛𝑡̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅̅ ̅
∗ 100 
Analysis of epithelial barrier integrity by dextran diffusion assay 569 
Dextran diffusion assays were performed according to Elamin et al. (79), with the following 570 
modifications. Briefly, fluorescein isothiocyanate (FITC)-labeled 4 kDa dextran beads (Sigma-571 
Aldrich) were used to analyze the permeability of differentiated C2BBe1 monolayers infected 572 
with 1×105 C. albicans cells/transwell-insert and/or Candidalysin for 24 h in serum- and pH 573 
indicator-free DMEM. After incubation, 30 µL of dextran beads (50 mg/mL in PBS) were 574 
added to the apical compartment and incubated for 3 h at 37°C and 5% CO2. Fluorescence 575 
(excitation 490 nm, emission 520 nm) of diffused dextran beads was measured in the 576 
basolateral transwell compartment. The background fluorescence of DMEM medium was 577 
subtracted from each value. Analyses were performed in duplicate and determined from at 578 
least three independent experiments. 579 
Analysis of apoptosis and necrosis 580 
Apoptosis and necrosis of differentiated C2BBe1 cells after infection with C. albicans was 581 
quantified using the Apoptotic/Necrotic/Healthy Cells Detection Kit (PromoKine) according 582 
to the manufacturer’s instructions. Differentiated C2BBe1 cells were infected with 583 
1×105 C. albicans cells/well for 5 h or 5×104 cells/well for 24 h, then washed and incubated 584 
for 15 min in the dark with FITC-Annexin V, Ethidium Homodimer III and Hoechst 33342. 585 
After washing, infected cells were examined by fluorescence microscopy (Zeiss Axio 586 
Observer). Uninfected, differentiated C2BBe1 cells were used as a negative control. 587 
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Treatment with 40% ethanol for 1 min was used as a positive control for necrosis and 588 
treatment with 2 µM Staurosporine as a positive control for apoptosis. 589 
The activity of caspase-3 and -7 was quantified using a Caspase-Glo 3/7 Assay (Promega) 590 
according to the manufacturer's instructions. Differentiated C2BBe1 cells in 96-well-plates 591 
were infected with 2×104 C. albicans cells/well for 5 h or 24 h. The volume of medium in 592 
each well was adjusted to 50 µL, and 50 μL of Caspase-Glo 3/7 reagent was added to each 593 
well, directly followed by luminescence measurements every 10 min for 2 h at RT in the dark 594 
using a microplate reader. Each measurement was performed in duplicate and the mean was 595 
calculated from three independent experiments. 596 
Cluster analysis and correlation coefficient calculation 597 
Cluster analysis enabled C. albicans mutants to be assigned into groups with similar behavior 598 
regarding the three measurements “epithelial damage”, “epithelial integrity” and “fungal 599 
translocation”, as described by the values LDH, TEER and translocation. Clusters were 600 
identified in Python using the scikit-learn library (82) applying the density-based spatial 601 
clustering of applications with noise (DBSCAN) algorithm (49). A cluster was detected if (i) it 602 
contained at least three members and (ii) the points were closer than 𝜖 = 35 percentage 603 
points (pp) to at least one other member. DBSCAN automatically finds the number of 604 
clusters and all points that are not considered part of any cluster were left unassigned. 605 
For correlation coefficient calculation, two of the three parameters epithelial damage 606 
(LDH)/epithelial integrity (TEER)/fungal translocation were plotted against each other, using 607 
the median response of all mutants as %Wt. For epithelial integrity, a TEER loss of 100% 608 
reflects the drop in TEER caused by the Wt, while the 100% LDH and translocation values are 609 
the epithelial damage and translocation of Wt. Both the Pearson and Spearman correlation 610 
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coefficients between measurements were calculated. To visualize overall trends, the Locally 611 
Weighted Scatterplot Smoothing (LOWESS) line was used (51, 80). To evaluate the linearity, 612 
or lack thereof, we fitted a first-order polynomial and an exponential function of the formula 613 
𝑦 = 𝐴𝑒−𝛼𝑥 + 𝐵, representing linear and non-linear relationships respectively. We evaluated 614 
whether the exponential fit added any information about the pairwise relationship by 615 
calculating the Bayesian Information Criterion (BIC) for each fit. The BIC is defined as 616 
𝐵𝐼𝐶 = 𝑛 ⋅ log
𝑅𝑆𝑆
𝑛
+ 𝑘 ⋅ log 𝑛, where 𝑛 is the number of fitted points, 𝑘 is the number of 617 
parameters in the model and 𝑅𝑆𝑆 is the sum of squared residuals (50). 618 
For the cluster analysis and correlation coefficient calculation, the median of the data was 619 
used to reduce the effect of outliers. 620 
Transmission electron microscopy of C. albicans-infected C2BBe1 cells 621 
Differentiated C2BBe1 cells were infected with 2×105 C. albicans cells/transwell. After 622 
coincubation for 24 h, cells were ﬁxed with Karnovsky ﬁxative (3% paraformaldehyde, 3.6% 623 
glutaraldehyde, pH 7.2) for 24 h at 4°C and post-ﬁxed with osmium-solution (1% OsO4 (Roth) 624 
and 1.5% potassium ferrocyanide (Morphisto)) for 2 h at 4°C. Samples were rinsed with 625 
distilled water, block-stained with uranyl acetate (2% in ddH2O), dehydrated in alcohol 626 
(stepwise 50–100%) and embedded in glycide ether (Serva) by polymerizing for 48 h at 60°C. 627 
Semi-thin sections of 1 µm were cut on an Ultracut Nova (Leica) with a diamond knife and 628 
stained with Toluidine blue stain (Morphisto) at 80°C. Regions of interest were ultrathin 629 
sectioned at 30 nm, mounted on copper grids and analyzed using a Zeiss LIBRA 120 630 
transmission electron microscope (Carl Zeiss) operating at 120 kV. 631 
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Statistical analysis 632 
All experiments were conducted including technical duplicates or triplicates (from which the 633 
mean value was calculated) on at least three independent occasions (biological replicates). 634 
Diagrams show the mean of the biological replicates with standard deviation (SD). Statistics 635 
relative to the Wt control were performed on Log transformed values by means of a 1-way 636 
ANOVA test with a follow-up test for multiple comparisons (Dunnett’s correction). When 637 
comparisons were made between selected datasets, a Bonferroni’s correction was used 638 
instead. TEER time curves were statistically tested using 2-way ANOVA.  639 
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Legends 879 
Figure 1: Infection of C2BBe1 IECs with Wt C. albicans. 880 
(A) Invasion of C. albicans into C2BBe1 cells at 3 h, 4.5 h and 6 h p.i. was quantified by 881 
differential fluorescence microscopy staining. The percentage of invasive hyphae relative to 882 
total C. albicans visible hyphae is shown. (B) Representative fluorescence microscopy images 883 
of differential staining to quantify C. albicans invasion (pink: extracellular C. albicans, blue: 884 
C. albicans, green: actin; white arrows indicate entry point of the invading hypha). (C) 885 
Quantification of C2BBe1 barrier integrity as measured by TEER, and fungal translocation 886 
(number of translocated cells) after infection with C. albicans SC5314. (D) Release of LDH 887 
from C2BBe1 cells after infection with C. albicans SC5314. Data are presented as mean ± SD 888 
of at least 3 independent experiments (n ≥ 3). 889 
Figure 2: Gene ontology (GO)-term analysis of hypo- and hyper-damaging mutants 890 
Gene deletions associated with significantly decreased (A) or increased (B) damage. 891 
Figure 3: In vitro characterization of selected C. albicans mutants on C2BBe1 IECs. 892 
(A) C2BBe1 IECs were infected with selected C. albicans mutants and cellular damage 24 h 893 
p.i. was quantified by LDH assay. Mean cellular damage induced by Wt C. albicans was 865 ± 894 
219 ng/mL LDH (dotted line). (B) The adhesion of selected C. albicans mutant strains to 895 
C2BBe1 IECs 1 h p.i. was quantified as described in the Method section. The mean adhesion 896 
of Wt C. albicans to C2BBe1 cells was 9.2 ± 5.7% (dotted line). (C) The invasion of selected 897 
C. albicans mutant strains into C2BBe1 IECs 5 h p.i. was quantified as described in the 898 
Method section. The mean invasion level of Wt C. albicans was 12.3 ± 5.9% (dotted line). (D) 899 
C2BBe1 IECs were infected with selected C. albicans mutants and their mean hyphal length 5 900 
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h p.i. was determined. The mean length of Wt C. albicans hyphae was 77.8 ± 12.6 µm 901 
(dotted line). All values are presented as mean ± SD relative to the Wt. Statistical 902 
significance: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. 903 
Figure 4: Characterization of damage, translocation and loss of TEER by selected and 904 
control mutants. 905 
(A) C. albicans gene-deletion mutants were analyzed for their ability to damage C2BBe1 IECs 906 
by LDH assay. (B) Translocation of C. albicans gene-deletion mutants across a differentiated 907 
C2BBe1 intestinal epithelial barrier. (C) Assessment of C2BBe1 epithelial barrier integrity in 908 
response to C. albicans gene-deletion mutants at 24 h p.i. as measured by loss of TEER. Data 909 
are expressed as TEER loss in  percentage of  Wt infected cells. Strains are arranged in 910 
clusters (I-III) according to bioinformatic analysis (cluster I = low damage, translocation and 911 
loss of TEER; cluster II = wild type like mutants; cluster III = low damage and translocation, 912 
but wild type like loss of TEER). All values are presented as median ± range relative to the Wt 913 
(dotted line). Statistical significance: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. 914 
Figure 5: Bioinformatic analysis of C. albicans-induced epithelial damage, loss of epithelial 915 
integrity and fungal translocation. 916 
Data obtained from C. albicans Wt and mutant strains for damage (LDH release), change in 917 
epithelial integrity (TEER) and translocation (CFUs) were analyzed. (A) Pairwise correlation 918 
analysis of epithelial damage (LDH), barrier integrity (TEER) and translocation (CFUs). In 919 
addition to the median value for each strain, the fit of a first order polynomial and an 920 
exponential fit is shown together with a LOWESS line that describes a parameter free 921 
smoothing to visualize the overall trend. The Bayesian Information Criterion (BIC) of each fit 922 
is given. Note that the strain sap1-3Δ/Δ is not visible, since it has extremely high 923 
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translocation values; this data point was, however, taken into account in the calculation of 924 
correlations and in the curve fitting. (B) Correlation coefficients of presented pairwise 925 
measurements. The respective p-values are calculated using a two-tailed Student’s t-test. 926 
Figure 6: Possible translocation mechanisms of C. albicans through IECs. 927 
(A) Schematic representation of possible routes of C. albicans translocation. I = apoptosis; II 928 
= paracellular; III = transcellular with damage; IV = transcellular without damage. TJ = Tight 929 
junctions; AJ = Adherens junctions; CaL = Candidalysin. (B) C2BBe1 IECs were infected with 930 
Wt C. albicans SC5314 for 5 h and 24 h and differentially stained (blue = living cells (Hoechst 931 
33342), green = apoptotic cells (FITC-Annexin V), red = necrotic cells (EthD-III) and red/green 932 
= late apoptotic/necrotic cells). Colored arrows indicate exemplary stained cells. (C) A 933 
summary of statistical analysis is presented (mean ± SD, n = 3) that quantifies the proportion 934 
of live-apoptotic-necrotic staining observed in (B). (D) Quantification of Caspase-3/7 activity 935 
in C2BBe1 IECs infected for 5 h and 24 h with C. albicans SC5314. Staurosporine was used as 936 
a positive control for the induction of apoptosis. Data is presented as mean ± SD of 3 937 
independent experiments (n = 3). (E) Transcellular growth of Wt C. albicans (BWP17 + Clp30) 938 
and ece1Δ/Δ mutant hyphae through C2BBe1 IECs. C2BBe1 cells were infected with 939 
C. albicans and differentially stained at 6 h p.i. (pink = extracellular C. albicans, blue = 940 
C. albicans, green = actin, arrows indicate point of invasion). (F) TEM images of C2BBe1 IECs 941 
infected with Wt C. albicans (BWP17 + Clp30) or ece1Δ/Δ mutant (C.a. = C. albicans; Cyt = 942 
Cytoplasm; ES = Extracellular Space; arrows indicate host membrane). 943 
Figure 7: Interaction of C. albicans ECE1 mutant strains with IECs. 944 
(A) Adhesion to C2BBe1 IECs in percentage of inoculated cells of C. albicans ECE1 mutant 945 
strains. (B) Invasion into C2BBe1 IECs in percentage of total visible hyphae of ECE1 mutant 946 
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strains. (C) C2BBe1 cells were infected with ECE1 mutant strains and the mean hyphal length 947 
of infecting fungi 6 h p.i. was quantified. (D) Quantification of LDH (damage), (E) analysis of 948 
epithelial barrier integrity by dextran mobility assay, (F) quantification of fungal 949 
translocation and (G) epithelial barrier integrity as measured by TEER in response to 950 
C. albicans ECE1 mutant strains are presented. (D-G) The application of exogenous 951 
Candidalysin toxin (alone) to C2BBe1 IECs, and in combination with infecting ECE1 mutant 952 
strains was assessed (CaL; 70 µM). Melittin (70 µM) was used as a positive control for 953 
damaging C2BBe1 cells. Data are presented as mean ± SD relative to the Wt, of at least 3 954 
independent experiments (n ≥ 3). Statistical significance: *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001. 955 
Figure S1: Induced endocytosis does not contribute to the overall invasiveness of 956 
C. albicans into C2BBe1 cells. 957 
Invasion of C2BBe1 IECs by Wt C. albicans SC5314 (in the presence of 0.5 µM Cytochalasin D, 958 
CytD) and UV-killed Wt C. albicans hyphae. Data are presented as mean ± SD of at least 3 959 
independent experiments (n ≥ 3). Statistical significance: *p ≤ 0.05. 960 
Figure S2: Average hypha length of selected C. albicans mutants. 961 
(A) Mean hypha length after 5 h on plastic in DMEM at 37°C, 5% CO2. Wt C. albicans (BWP17 962 
+ Clp30) was 124.8 ± 39.2 µm (dotted line); n ≥ 3. Statistical significance: *p ≤ 0.05; 963 
***p ≤ 0.001. 964 
Figure S3: Control experiments for Candida strains analyzed in the in vitro translocation 965 
model. 966 
(A) Translocation of C. albicans gene-deletion mutants across a transwell membrane in the 967 
absence of C2BBe1 IECs. Data are presented as a mean ratio of mutant to Wt blank 968 
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translocation (n ≥ 3). The same blank translocation ability of mutant and Wt would result in a 969 
ratio of 1 (dotted line). (B) C. albicans gene-deletion mutants were assessed for their 970 
sensitivity to Zymolyase. (C) Growth curve analysis of C. albicans gene-deletion mutant 971 
strains in YPD broth at 30°C. The mutants in all graphs are separated according to cluster 972 
analysis. (B and C) Data are presented as mean ± SD of at least 3 independent experiments 973 
(n ≥ 3). Statistical significance: *p ≤ 0.05. 974 
Figure S4: Cluster analysis of C. albicans mutants. 975 
Assignment of C. albicans mutants into different clusters, according to epithelial damage, 976 
epithelial integrity and fungal translocation, by bioinformatic cluster analysis using DBSCAN. 977 
Clusters are shown in graph (A) and individual mutants are listed in table (B). 978 
 979 
Figure S5: In vitro translocation model. 980 
(A) Schematic representation of the established in vitro translocation model. C2BBe1 cells 981 
were grown and differentiated on a porous membrane in a transwell system. After infection 982 
with C. albicans, changes in epithelial integrity were determined by measurement of TEER. 983 
Fungal translocation from the apical side of the transwell to the basolateral compartment 984 
was quantified after Zymolyase treatment via CFU count. (B) PAS-staining of a cross-section 985 
through a transwell membrane with differentiated C2BBe1 cells after Wt C. albicans 986 
infection. (C) TEM image of C2BBe1 cells after 14 days of differentiation in the transwell 987 
system. Cells form a confluent monolayer with brush border (arrow) on the apical surface. 988 
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Table S1: C. albicans mutants analyzed in this study. 989 
Table S2: C. albicans mutants analyzed for cellular damage, impact on epithelial integrity 990 
and fungal translocation. 991 
Data Set S1: C. albicans mutants screened for epithelial damage using Caco-2 cells via LDH 992 
assay. C. albicans mutant collections from Noble et al. (41), Homann et al. (43) and Nobile & 993 
Mitchell (42) were screened for their ability to damage Caco-2 cells 24 h p.i. by LDH release. 994 
The mean LDH release in % high control is shown for each mutant strain tested.  995 
Data Set S2: C. albicans hypo- and hyper damaging mutants. 996 
C. albicans gene-deletion mutants were screened for their ability to damage Caco-2 cells 997 
24 h p.i. by LDH release. 172 hypo-damaging and 102 hyper-damaging gene-deletion 998 
mutants were identified and ordered according to damage caused (%Wt). Putative gene 999 
function, fungal morphology on Caco-2 cells and growth in YPD broth at 30°C are presented 1000 
(%Wt, X = defective compared to Wt). 1001 
Data Set S3: Primers used in this study. 1002 







